Center of Excellence: A center of excellence (COE) brings together people from different disciplines and provides shared facilities/resources
JDRF Centers of Excellence are intended to support Universities and/or Research Institutes that have a track record of excellence in T1D research to develop and pursue collaborative research programs that drive towards translational outcomes and clinical impact and are aligned with JDRF Research goals.
Read More
On Saturday, May 16, 2020, the JDRF Greater Bay Area Chapter will host the 22nd Annual Hope Gala, bringing prominent business leaders and families from around the Bay Area to The Ritz-Carlton, San Francisco for an evening of fundraising, celebration, and networking.
Read More
JDRF, the leading global organization funding type 1 diabetes (T1D) research, today announced the launch of the JDRF Northern California Center of Excellence, to accelerate high-impact research at Stanford University and the University of California, San Francisco, to develop cures for T1D.
Read More
UCSF Aldea Center CoE Kickoff symposium agenda
Read More
Professor and the Anthony DiGenova Endowed Faculty Scholar, , Stanford University
Type 1 Diabetes in an autoimmune disease. Therefore, the ability to efficiently generate human immune cell-types in vitro, and to engineer them with desired combinations of mutations, could be used to eventually understand and treat Type 1 Diabetes. To this end, the Loh group seeks to reconstitute the development of human blood-forming hematopoietic stem cells (HSCs) and T cells in vitro from human pluripotent stem cells (hPSCs). Advances by the Loh Laboratory have led to strategies for efficiently generating primitive streak, endoderm and foregut precursors from hPSCs.
Read More